Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Big Pharma lost in court - Congress must not bail it out
For the last three years, some of the most profitable corporations in the world spent millions of dollars in court attempting to reverse the biggest defeat the pharmaceutical industry suffered in decades. The Supreme Court recently declined even to…
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 24 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, June 10, 2026 –…
Pharma Foods Intl 9-Mos Loss Y1.06B Vs Loss Y1.12B
Pharma Foods International Co. Ltd. (2929.TO) Japan Nine Months Ended April 30 GROUP 2026 2025 Revenue Y48.56 bln Y46.82 bln Operating Profit (Y1.43 bln) (Y217.00 mln) Pretax Profit (Y1.55 bln) (Y231.00 mln) Net Profit (Y1.06 bln) (Y1.12 bln) Per…
The looming China pharma choke point
U.S. drug development is heavily dependent on China — and Washington is not keeping up with the whole-of-government response many experts say is needed to change that. Why it matters: The U.S. is being held back by vulnerabilities like…
China focus: Livestream commerce, Sirio Pharma, HMO infant formulas and more
News from China including new draft rules for livestream commerce, Sirio Pharma's entry into Aussie gummy supplement market, growth of HMO infant formulas…
Acadia Pharma Must Face Investors' Drug Approval Claims
Acadia Pharmaceuticals must face investors' class action claims it misstated the likelihood that it would get regulatory approval to market its psychosis drug pimavanserin for expanded use, a California federal judge... To view the full article…
Pharma exports to clock $50 billion by 2030: Ministry official
The Indian pharmaceutical industry has grown from about $20 billion in 2014 to nearly $60 billion in 2026, and is expected to touch $130 billion by 2030, with exports alone looking to clock $50 billion, said Mohit Yadav, Joint Secretary, Department…
BridgeBio Pharma, Inc. $BBIO Position Lifted by Franklin Resources Inc.
Franklin Resources Inc. raised its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 49.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned…
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO). In a filing disclosed on June 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in…
BridgeBio Pharma, Inc. $BBIO Shares Acquired by GW&K Investment Management LLC
GW&K Investment Management LLC increased its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 4.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange…
TD Asset Management Inc Has $9.19 Million Holdings in Royalty Pharma PLC $RPRX
TD Asset Management Inc raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 22.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 237,897 shares of the biopharmaceutical…
Royalty Pharma PLC (NASDAQ:RPRX) Given Consensus Recommendation of 'Buy' by Analysts
Shares of Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) have received a consensus rating of 'Buy' from the seven ratings firms that are currently covering the company, Marketbeat reports. Seven research analysts have rated the stock with a buy…
Which Industries Will Give Bigger Salary Hikes?
'While salary increments are moderating compared to last year, not all functions are moving at the same pace.' Salary increments across industries are expected to range between 8.6 per cent and 10.2 per cent in 2026-2027 (FY27), narrowing from the…
Nxera Joins OpenFold AI Research Consortium Alongside Leading Global Pharmaceutical and AI Companies to Accelerate AI-enabled Drug Discovery
Tokyo, Japan and Cambridge, UK, 10 June 2026 – Nxera Pharma Co., Ltd. (“Nxera” or the “Company”) announces that it has joined OpenFold, a non-profit AI research consortium that promotes the development of…
CenterBook Partners LP Has $2.71 Million Position in Royalty Pharma PLC $RPRX
CenterBook Partners LP lessened its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 20.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned…
Receive a Daily briefing on Pharma Industry News
Get Started